Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy

Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is a critical problem with an impact on both oncological and cardiovascular prognosis, especially when it prevents patients from receiving cancer treatment. Standard therapy for heart failure (HF) is recommended for CTRCD, but th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vanesa Gregorietti, Teresa Lopez Fernandez, Diego Costa, Elías Ortega Chahla, Andrés J. Daniele
Format: Artigo
Jezik:Inglês
Izdano: BMC 2020-11-01
Serija:Cardio-Oncology
Teme:
Heart failure
Cancer
Cardiotoxicity
Sacubitril/valsartan
Online dostop:http://link.springer.com/article/10.1186/s40959-020-00078-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki